1 дек. 2023 г. · Furthermore, a larger, recent study demonstrated long-term ventilation tube placement was effective in controlling vertigo in 62% of patients ( ...

31 июл. 2024 г. · SPI-1005 is the only investigational new drug that was tested in a Phase 3 trial aimed at improving hearing loss, tinnitus, and/or dizziness ...

11 мая 2023 г. · The study revealed that 10% of MD patients had migraine compared to the 3.5% of healthy individuals, demonstrating a 2.22-fold higher risk of ...

There is a gap in knowledge surrounding hearing loss in Ménière's disease. The underlying cause is not yet known, and current treatment and prevention methods ...

2 авг. 2024 г. · SPI-1005 is the only investigational new drug that was tested in a Phase 3 trial aimed at improving hearing loss, tinnitus, and/or dizziness ...

1 авг. 2024 г. · Sound Pharmaceuticals has concluded the Phase III clinical trial of SPI-1005, an investigational anti-inflammatory therapy aimed at treating Meniere's disease.

1 окт. 2023 г. · Recent findings: Intratympanic steroid and intratympanic gentamicin injections continue to be widely used as in-office therapies in medically ...

Research projects supported by the Ménière's Society. Assessment and Management of Psychological Symptoms in Vestibular Disorders Dr L Smith, University of ...

1 мар. 2024 г. · In establishing the Meniere's Disease Neuroscience Laboratory, he will launch a new international research program into the disease.

7 авг. 2023 г. · Elaborate 3D analysis of the inner ear now, for the first time, provide insights into volume changes of special structures in sufferers of the so-called Méniè ...